What's Juno Therapeutics Worth To Celgene?

Celgene Corp. (NASDAQ: CELG) owns ex-U.S. rights to Juno Therapeutics' (NASDAQ: JUNO) lead drug, liso-cel (formerly JCAR017), and it owns nearly 10% of Juno Therapeutics' stock, yet that may not be enough to satisfy Celgene's desire to become a gene-therapy leader. According to The Wall Street Journal, Celgene is thinking about acquiring Juno Therapeutics outright.

BING NEWS:
  • Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
    Buying $1000 In VKTX: If an investor had bought $1000 of VKTX stock 5 years ago, it would be worth $8,726.15 today based on a price of $77.75 for VKTX at the time of writing.
    05/1/2024 - 5:00 am | View Link
  • PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that PTC Therapeutics would post earnings of $0.29 ...
    04/19/2024 - 8:27 pm | View Link
  • Medical Science and Genius-Level Technology Are Coming To Smarten Up Your Skin-Care Routine
    Nearly five years later, the brand has expanded dramatically, not only selling a routine worth of skin-care products ... engineers, medical diagnostics developer Rathi Srinivas and therapeutics ...
    01/2/2024 - 6:13 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News